You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME

Ischemic Heart Disease: Mitigating the Risk of Sudden Cardiac Death

  • Authors: Deepak L. Bhatt, MD, MPH; Roxana Mehran, MD; William S. Weintraub, MD
  • CME Released: 2/26/2013; Reviewed and Renewed: 9/2/2015
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 9/2/2016
Start Activity


Target Audience and Goal Statement

This activity is intended for electrophysiologists, interventional cardiologists, clinical cardiologists, and other allied healthcare professionals.

The goal of this activity is to enhance the ability to risk stratify patients at risk for sudden cardiac death immediately after percutaneous coronary intervention (PCI) so as to apply appropriate therapy.

Upon completion of this activity, participants will be able to:

  1. Review the derivation of the CADILLAC risk score recognizing the risk factors for sudden cardiac death after PCI
  2. Review data examining mortality risk after PCI
  3. Identify treatment strategies to prevent sudden cardiac death in vulnerable patients following PCI


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Authors

  • Deepak L. Bhatt, MD, MPH

    Chief of Cardiology, VA Boston Healthcare System; Senior Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts

    Disclosures

    Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Amarin Corporation plc; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Ethicon, Inc.; Medtronic, Inc.; Sanofi; The Medicines Company

    Dr Bhatt does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Bhatt does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Roxana Mehran, MD

    Professor of Medicine and Health Policy; Director, Interventional Cardiovascular Research and Clinical Trials, The Mount Sinai Medical Center, New York, New York

    Disclosures

    Disclosure: Roxana Mehran, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Abbott Laboratories; AstraZeneca Pharmaceuticals LP; Maya Medical, Inc.; Merck & Co., Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Regado Biosciences
    Received grants for clinical research from: Bristol-Myers Squibb Company; Sanofi; The Medicines Company; Lilly USA, LLC; Daiichi Sankyo, Inc.

    Dr Mehran does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Mehran does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • William S. Weintraub, MD, FACC

    John H. Ammon Chair, Section of Cardiology; Director, Christiana Center for Outcomes Research, Christiana Care Health System, Newark, Delaware

    Disclosures

    Disclosure: William S. Weintraub, MD, has disclosed no relevant financial relationships.

    Dr Weintraub does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the US Food and Drug Administration (FDA) for use in the United States.

    Dr Weintraub does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

  • Ronald K. Miller, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Ronald K. Miller, PhD, has disclosed no relevant financial relationships.

Acute MI Steering Committee

  • Deepak L. Bhatt, MD, MPH

    Disclosures

    As listed above.

  • Roberta C. Bogaev, MD

    Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas; Private Practice Cardiologist, Schnitzler Cardiovascular Consultants, San Antonio, Texas

    Disclosures

    Disclosure: Roberta C. Bogaev, MD, has disclosed no relevant financial relationships.

  • Ted E. Feldman, MD

    Professor of Medicine, Northwestern University School of Medicine, Evanston, Illinois

    Disclosures

    Disclosure: Ted E. Feldman, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific; Coherex Medical, Inc.; Edwards Lifesciences; Intervalve; Daiichi Sankyo, Inc.; Lilly USA, LLC; W.L. Gore & Associates, Inc.
    Served as a speaker or a member of a speakers bureau for: Boston Scientific
    Received grants for clinical research from: Abbott Laboratories; Boston Scientific; Edwards Lifesciences; St. Jude Medical; W.L. Gore & Associates, Inc.

  • Jagmeet P. Singh, MD, PhD

    Associate Professor of Medicine, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Harvard Medical School, Boston, Massachusetts

    Disclosures

    Disclosure: Jagmeet P. Singh, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: BIOTRONIK; Boston Scientific; Medtronic, Inc.; St. Jude Medical; Sorin Group; CardioInsight Technologies Inc.; Thoratec Corporation
    Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group
    Received grants for clinical research from: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group; Medtronic, Inc.

CME Reviewer(s)

  • Nafeez Zawahir, MD

    CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME

Ischemic Heart Disease: Mitigating the Risk of Sudden Cardiac Death

Authors: Deepak L. Bhatt, MD, MPH; Roxana Mehran, MD; William S. Weintraub, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME Released: 2/26/2013; Reviewed and Renewed: 9/2/2015

Valid for credit through: 9/2/2016

processing....

This feature requires the newest version of Flash. You can download it here.
  • Print